INSIGHTS ON DRUG DEVELOPMENT
-
Modeling Virus Evolution, Rapid Drug Repurposing With Human Airway Lung-Chips
In this presentation, we introduce the human Airway Lung-Chip, which can model influenza virus infection and evolution in vitro and evaluate therapeutics for both influenza and SARS-CoV-2.
-
Formulation Of Crystalline Nanoparticles Enabling Superior Drug Load
Explore how bioavailability of poorly soluble APIs can be improved and patient compliance enhanced by reducing the size or number of tablets that a patient must take to achieve the required dose.
-
The Simplest, Most Powerful Digital PCR Workflow Family
Scalable digital PCR provides high-throughput automation for up to 384 samples. Support seven-color multiplexing and 3D data analysis to achieve superior sensitivity and streamlined laboratory workflows.
-
Optical Microscopy For Process Monitoring And Product Characterization
Modern optical microscopy reveals cellular activity and material quality with exceptional clarity. See how tailored, feature‑rich imaging systems help researchers generate high‑value data.
-
Improving In Vitro Cancer Modeling8/2/2024
Organ-on-a-Chip technology represents a significant advancement in drug discovery. By mimicking human physiology, Organ-Chips can enhance the predictive accuracy of preclinical models and accelerate drug development.
-
The Art And Science Of Topical Formulations7/3/2025
Chief Scientific Officer Jon Lenn discusses the balance of art and science in topical formulation development, emphasizing advanced skin models for optimized delivery, activity, and product stability.
-
Exosome Production From hMSC Using A Fixed-Bed Bioreactor11/3/2025
Explore a high-yield, scalable process for hMSC-derived exosome production using fixed-bed bioreactors, with strong performance in purity, recovery, and biological activity.
-
Non Animal Origin Squalene For High-Risk Applications7/21/2025
Explore an ethical and sustainable alternative to shark-derived squalene that is backed by robust data to deliver identical performance in vaccine formulations without environmental compromise.
-
A Scientist's Perspective: Minimizing Hands-On Time In Molecular Assays3/26/2026
Autonomous digital PCR provides absolute quantification in complex matrices. Achieve five-color multiplexing and streamlined data collection without standard curves to accelerate synthetic biology.
DRUG DEVELOPMENT SOLUTIONS
-
Reproducibility, reliability and carryover performance that meets your workflow demands, injection to injection, batch after batch.
ExionLC 2.0 and ExionLC 2.0+ systems provide full integration, control and compatibility with SCIEX mass spectrometers bringing together the speed and precision you expect for a complete solution that meets every challenge your lab faces.
-
STELLARIS 8 FALCON FLIM Microscope
The contrast is clear. Lifetime imaging in an instant.
STELLARIS 8 FALCON (FAst Lifetime CONtrast) is the future of functional imaging. Harness the power of fluorescence lifetime to investigate cellular physiology and explore dynamics in living cells. STELLARIS 8 FALCON is a fully integrated solution for Fluorescence Lifetime Imaging (FLIM) and enables video-rate lifetime imaging acquisition for rapid kinetic studies in live cells.
STELLARIS 8 FALCON adds a new dimension of contrast to your imaging, opening the door to biosensing and tracking of interactions between proteins. FLIM information is now available for all modalities of the STELLARIS 8 system.
-
Discover three solutions that provide the performance, reliability, and ease-of-use required for the most demanding applications in drug discovery, protein-protein interactions, structure-function characterization, and more.
-
Ensure patient safety and product efficacy with high-quality pharmaceutical excipients that are designed to streamline regulatory approval and support sterile liquid drug formulation development.
-
Partner with a trusted, globally proven CDMO whose world-class, rapidly scalable facilities and unwavering commitment to quality help accelerate patient access to life-saving biologics.